Abstract
Systemic vasculitides, including Wegener’s granulomatosis and Churg-Strauss Syndrome, may be associated with nasal manifestations such as allergic and non-allergic rhinitis, chronic rhinosinusitis with and without nasal polyps. Management of systemic vasculitides require a multidisciplinary approach and is based on clinical, histopathological, and immunological features for the diagnosis, and on oral steroids and immunosuppressive agents for the treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amezcua-Guerra LM, Prieto P, Bojalil R et al (2006) Microscopic polyangiitis associated with primary biliary cirrhosis: a causal or casual association? J Rheumatol 33: 2351–2353
Boccagni C, Tesser F, Mittino D et al (2004) Churg–Strauss syndrome associated with the leukotriene antagonist montelukast. Neurol Sci 25:21–22
Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27:277–301
Cuchacovich R, Justiniano M, Espinoza LR (2007) Churg–Strauss syndrome associated with leukotriene receptor antagonists (LTRA). Clin Rheumatol 26:1769–1771
De Groot K, Rasmussen N, Bacon PA et al (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic anti-neutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52:2461–2469
Devaney KO, Travis WD, Hoffman GS et al (1990) Interpretation of head and neck biopsies in Wegener’s granulomatosis. A pathologic study of 126 biopsies in 70 patients. Am J Surg Pathol 14:555–564
Ferri C, Zignego AL, Pileri SA (2002) Cryoglobulins. J Clin Pathol 55:4–13
Gencik M, Meller S, Borgmann S et al (2000) Proteinase 3 gene polymorphisms and Wegener’s granulomatosis. Kidney Int 58:2473–2477
Gross WL (2002) Churg–Strauss syndrome: update on recent developments. Curr Opin Rheumatol 14:11–14
Guillevin L, Lhote F (1998) Treatment of polyarteritis nodosa and microscopic polyangiitis. Arthritis Rheum 41: 2100–2105
Guillevin L, Lhote F, Gayraud M et al (1996) Prognostic factors in polyarteritis nodosa and Churg–Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28
Hoffman GS, Kerr GS, Leavitt R et al (1992) Wegener’s granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498
Jayne D (2005) How to induce remission in primary systemic vasculitis. Best Pract Res Clin Rheumatol 19:293–305
Jayne D, Rasmussen N, Anfrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with anti-neutrophil cytoplasmic antibodies. N Engl J Med 349:36–44
Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitis. Proposal of an international consensus conference. Arthritis Rheum 37:187–192
Keogh KA, Specks U (2003) Churg–Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 115:284–290
Langford CA (2001) Treatment of polyarteritis nodosa, microscopic polyangiitis, and Churg–Strauss syndrome: where do we stand? Arthritis Rheum 44:508–512
Langford CA, Sneller MC, Hallahan CW et al (1996) Clinical features and therapeutic management of subglottic stenosis in patients with Wegener’s granulomatosis. Arthritis Rheum 39:1754–1760
Lhote F, Cohen P, Guillevin L (1998) Polyarteritis nodosa, microscopic polyangiitis and Churg–Strauss syndrome. Lupus 7:238–258
Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg–Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094–1100
Matteson EL (1998) Small-vessel vasculitis. N Engl J Med 338:994–995
Metaxaris G, Prokopakis EP, Karatzanis AD et al (2002) Otolaryngologic manifestations of small vessel vasculitis. Auris Nasus Larynx 29:353–356
Noth I, Strek ME, Leff AR (2003) Churg–Strauss syndrome. Lancet 361:587–594
Oristrell SJ, Bosch JA, Valdes OM et al (1985) Polyarteritis nodosa and perforation of the nasal septum. Med Clin (Barc) 84:673–674
Sansonno D, Damacco F (2005) Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227–236
Seo P (2008) Wegener’s granulomatosis: managing more than inflammation. Curr Opin Rheumatol 20:10–16
Seo P, Stone JH (2004) The anti-neutrophil cytoplasmic antibody-associated vasculitides. Am J Med 117:39–50
Smith I, Smith M, Mathias D et al (1996) Cryoglobulinaemia and septal perforation: a rare but logical cause. J Laryngol Otol 110:668–669
Stegeman CA, Tervaert JW, Sluiter WJ et al (1994) Association of chronic nasal carriage of S. aureus and higher relapse rates in Wegener’s granulomatosis. Ann Intern Med 120:12–17
Watts R, Lane S, Scott DG (2005) What is known about the epidemiology of systemic vasculitis? Best Pract Res Clin Rheumatol 19:191–207
Wegener’s Granulomatosis Etanercept Trial (WGET) Research Group (2005) Etanercept plus standard therapy for Wegener’s granulomatosis. N Engl J Med 352:351–360
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Alobid, I., Mullol, J. (2010). Vasculitis Including Churg–Strauss Syndrome. In: Önerci, T., Ferguson, B. (eds) Nasal Polyposis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11412-0_16
Download citation
DOI: https://doi.org/10.1007/978-3-642-11412-0_16
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-11411-3
Online ISBN: 978-3-642-11412-0
eBook Packages: MedicineMedicine (R0)